Investment Counselors of Maryland’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-189,104
Closed -$13.3M – 214
2015
Q2
$13.3M Hold
189,104
– – 0.62% 94
2015
Q1
$15M Sell
189,104
-38,000
-17% -$2.8M 0.71% 82
2014
Q4
$14.5M Sell
227,104
-79,875
-26% -$5.01M 0.7% 78
2014
Q3
$18.3M Sell
306,979
-44,603
-13% -$2.55M 0.91% 50
2014
Q2
$18.8M Sell
351,582
-3,518
-1% -$193K 0.81% 69
2014
Q1
$21.4M Sell
355,100
-31,500
-8% -$1.84M 0.91% 47
2013
Q4
$20.5M Sell
386,600
-10,200
-3% -$512K 0.84% 56
2013
Q3
$18.4M Buy
396,800
+10,350
+3% +$475K 0.78% 62
2013
Q2
$15.9M Buy
+386,450
New +$16.6M 0.7% 67

Other funds holding CRL

Investment Counselors of Maryland's CRL Position: Q3 2015 in Review

Investment Counselors of Maryland sold out of Charles River Laboratories (CRL) in Q3 2015, closing a stake of 189,104 shares — an estimated $13.3M sold.

Investment Counselors of Maryland first reported a position in CRL in Q2 2013 and held it in 9 quarters. The position peaked at $21.4M in Q1 2014. 258 funds tracked by Wall St. Rank hold CRL as of Q3 2015.

  • Investment Counselors of Maryland reported no remaining Charles River Laboratories position as of Q3 2015 after selling out during the quarter.
  • Investment Counselors of Maryland sold 189,104 Charles River Laboratories shares in Q3 2015, an estimated $13.3M.
  • Investment Counselors of Maryland first reported a position in Charles River Laboratories in Q2 2013 and held it in 9 quarters.
  • Investment Counselors of Maryland's Charles River Laboratories position peaked at $21.4M in Q1 2014.
  • 258 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2015.

Based on Investment Counselors of Maryland's 13F filing for Q3 2015, filed 3 Nov 2015.